# Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer

> **NCT07517107** · PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 600 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Circulating Tumor DNA (ctDNA) Analysis
- **DRUG:** Standard Systemic Therapy for Gastric Cancer

## Key facts

- **NCT ID:** NCT07517107
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-10-01
- **Final completion:** 2029-10-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07517107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07517107, "Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07517107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*